Source link : https://www.newshealth.biz/health-news/minimal-risks-with-sbrt-in-stage-i-nsclc/
TOPLINE: Patients with stage I non–small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) have a low rate of acute toxicities and 90-day mortality, according to a recent study evaluating real-world patient outcomes. METHODOLOGY: SBRT is generally considered a safe treatment option in patients with stage I NSCLC who have medically inoperable tumors […]
Author : News Health
Publish date : 2024-09-26 13:08:39
Copyright for syndicated content belongs to the linked Source.
Categories